Related Experiment Videos
Retinopathy of prematurity: recent advances in our understanding
C M Wheatley1, J L Dickinson, D A Mackey
1Discipline of Biochemistry, University of Tasmania, Hobart, Tasmania 7001, Australia.
Insights
Retinopathy of prematurity (ROP) is a leading cause of childhood blindness, increasing in developing nations. Research highlights genetic factors and the need for screening and treatment to prevent vision loss.
Area of Science:
- Ophthalmology
- Genetics
- Neonatology
Background:
- Retinopathy of prematurity (ROP) has been a significant cause of childhood visual impairment and blindness since the 1940s.
- While ROP incidence and severity have declined in developed countries, they are rising in developing nations.
- ROP is recognized as an important, yet preventable, disease.
Purpose of the Study:
- To provide an updated summary and discussion of research on retinopathy of prematurity.
- To examine the prevalence, risk factors, and potential causes of ROP, with a focus on genetic studies.
- To inform strategies for ROP prevention and management.
Main Methods:
- Review of population, animal, cell culture, and genetic research.
- Analysis of ROP prevalence and risk factors.
- Focus on genetic studies to understand disease etiology.
Main Results:
- Significant reductions in ROP have been achieved in developed countries.
- ROP incidence and severity are increasing in developing nations.
- Genetic research offers insights into the disease's causes.
Conclusions:
- Further research is essential for a complete understanding and prevention of ROP.
- Developing and implementing effective screening and treatment strategies are crucial for reducing ROP-related blindness, especially in developing countries.
Abstract:
Retinopathy of prematurity (ROP) has been recognised as an important cause of childhood visual impairment and blindness since the 1940s when improved facilities and treatment increased the survival rate of premature infants. Although its incidence and severity have been decreasing in developed countries over the past two decades, both are increasing in developing nations. ROP is consequently targeted as an important but avoidable disease. This review provides an updated summary and discussion of much of the work that has been produced through population, animal, cell culture, and genetic research. The authors examine the prevalence, risk factors, and possible causes of the disease with a particular focus on genetic studies. They conclude that while significant reductions in the disease have occurred in developed countries, further research is required to fully understand and prevent the disease. In the meantime, development and implementation of appropriate screening and treatment strategies will be critical in reducing blindness in developing countries.